Lymphodepletion with high-dose interleukin-2 (IL-2) and granulocyte macrophage-colony stimulating factor (GM-CSF) in metastatic melanoma patients: An interim analysis.

被引：0
|
作者：
Ketchum, S. L.
Cole, B.
Margolin, K.
McDermott, D.
Crocenzi, T.
Roberts, J.
Crosby, N.
Meehan, K.
Fisher, J.
Ernstoff, M. S.
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Harvard Univ, Cambridge, MA 02138 USA
[3] Virginia Commonwealth Univ, Richmond, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8034
引用
收藏
页码：461S / 461S
页数：1
相关论文
共 50 条
  • [31] Interleukin 2 (IL-2) and granulocyte-macrophage colony stimulating factor (sargramostin) (GM-CSF) following autologous peripheral blood stem cell transplant (ASCT) for breast cancer
    Holmberg, LA
    Bensinger, W
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 98 - 99
  • [32] Effect of granulocyte macrophage-colony stimulating factor (GM-CSF, sargramostim) administration on serum S100B and its subtypes in melanoma patients
    De Gast, B.
    Korse, C.
    Weber, R.
    Trautveter, S.
    Bonfrer, J.
    Spitler, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] SIMULTANEOUS INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) ADMINISTRATION AFTER HIGH-DOSE CHEMOTHERAPY (HDCT) IN PATIENTS WITH ADVANCED CANCER
    BOWERS, C
    ADKINS, D
    DUNPHY, F
    PETRUSKA, P
    VELASQUEZ, W
    MCINTYRE, W
    NIEMEYER, R
    RESTA, D
    SPITZER, G
    BLOOD, 1993, 82 (10) : A495 - A495
  • [34] GROWTH OF AN INTERLEUKIN-2 INTERLEUKIN 4-DEPENDENT T-CELL LINE INDUCED BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF)
    KUPPER, T
    FLOOD, P
    COLEMAN, D
    HOROWITZ, M
    JOURNAL OF IMMUNOLOGY, 1987, 138 (12): : 4288 - 4292
  • [35] Effects of Combined Granulocyte–Macrophage Colony-Stimulating Factor (GM-CSF), Interleukin-2, and Interleukin-12 based Immunotherapy against Intracranial Glioma in the Rat
    Walter C. Jean
    Stephen R. Spellman
    Margaret A. Wallenfriedman
    Christine T. Flores
    Brian P. Kurtz
    Walter A. Hall
    Walter C. Low
    Journal of Neuro-Oncology, 2004, 66 : 39 - 49
  • [36] Cancer gene therapy treatment using adenoviral thymidine kinase (TK)/ganciclovir (GCV) plus adeno granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin-2 (IL-2) immunotherapy
    Chiang, YH
    CANCER GENE THERAPY, 1999, 6 (06) : S19 - S19
  • [37] Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
    Yee Chung Cheng
    Gabriela Rondón
    Leah F. Sanchez
    John D. McMannis
    Daniel R. Couriel
    Marcos J. de Lima
    Chitra Hosing
    Issa F. Khouri
    Sergio A. Giralt
    Richard E. Champlin
    Naoto T. Ueno
    International Journal of Hematology, 2009, 90 : 627 - 634
  • [38] Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
    Cheng, Yee Chung
    Rondon, Gabriela
    Sanchez, Leah F.
    McMannis, John D.
    Couriel, Daniel R.
    de Lima, Marcos J.
    Hosing, Chitra
    Khouri, Issa F.
    Giralt, Sergio A.
    Champlin, Richard E.
    Ueno, Naoto T.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 90 (05) : 627 - 634
  • [39] A pilot study of paclitaxel combined with gemcitabine followed by interleukin-2 and granulocyte macrophage colony-stimulating factor for patients with metastatic melanoma
    Peng, Rui-Qing
    Ding, Ya
    Zhang, Xing
    Liao, Yuan
    Zheng, Li-Min
    Zhang, Xiao-Shi
    CANCER BIOLOGY & THERAPY, 2012, 13 (14) : 1443 - 1448
  • [40] Response to high-dose interleukin-2 (HD IL-2) therapy in patients with brain metastases from metastatic melanoma
    Powell, S. F.
    Dudek, A. Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345